World's Best Scientists 2026 revealed!
David P. Nicolau

David P. Nicolau

D-Index & Metrics

Microbiology

D-Index
85
Citations
28418
World Ranking
870
National Ranking
402

Medicine

D-Index
86
Citations
29376
World Ranking
14058
National Ranking
7130

David P. Nicolau publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where David P. Nicolau sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 814 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

David P. Nicolau D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where David P. Nicolau sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 85 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

David P. Nicolau is affiliated with Hartford Hospital in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to Pharmacology, Molecular Medicine, Epidemiology, Molecular Biology, and Pediatrics, Perinatology and Child Health.

The main topics of Nicolau's work include Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria, Bacterial Biofilms and Quorum Sensing, Pneumonia and Respiratory Infections, Pharmacological Effects and Toxicity Studies, Antibiotic Use and Resistance, and Pharmaceutical Studies and Practices.

The scientist has published extensively in several venues, with the most frequent publication outlets being:

  • Journal of Antimicrobial Chemotherapy
  • Open Forum Infectious Diseases
  • Journal of Medicinal Chemistry
  • ACS Infectious Diseases
  • Antimicrobial Agents and Chemotherapy

Recent papers authored or co-authored by David P. Nicolau include:

  • A Modular Synthetic Route Involving N-Aryl-2-nitrosoaniline Intermediates Leads to a New Series of 3-Substituted Halogenated Phenazine Antibacterial Agents, 2021, Journal of Medicinal Chemistry
  • Transcript Profiling of Nitroxoline-Treated Biofilms Shows Rapid Up-regulation of Iron Acquisition Gene Clusters, 2022, ACS Infectious Diseases
  • Assessing the in vivo efficacy of rational antibiotics and combinations against difficult-to-treat Pseudomonas aeruginosa producing GES β-lactamases, 2023, Journal of Antimicrobial Chemotherapy
  • Pharmacokinetics and soft-tissue distribution of tebipenem pivoxil hydrobromide using microdialysis: a study in healthy subjects and patients with diabetic foot infections, 2022, Journal of Antimicrobial Chemotherapy
  • Defining optimal sulbactam regimens for treatment of Acinetobacter baumannii pneumonia and impact of blaOXA-23 on efficacy, 2024, Journal of Antimicrobial Chemotherapy

Frequent collaborators in their work include:

  • David P. Nicolau
  • Joseph L. Kuti
  • Christian M. Gill
  • Aliaa Fouad
  • Yuwei Shen

Best Publications

  • Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.

    D P Nicolau;C D Freeman;P P Belliveau;C H Nightingale

  • Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections

    Chonghua Li;Xiaoli Du;Joseph L. Kuti;David P. Nicolau

  • Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.

    Collin D. Freeman;David P. Nicolau;Paul P. Belliveau;Charles H. Nightingale

  • Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection

    Melinda K. Lacy;Wen Lu;Xiaowei Xu;Pamela R. Tessier

  • The pharmacodynamics of aminoglycosides

    Melinda K. Lacy;David P. Nicolau;Charles H. Nightingale;Richard Quintiliani

  • Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem.

    Joseph L. Kuti;Prachi K. Dandekar;Charles H. Nightingale;David P. Nicolau

  • Pharmacokinetic and Pharmacodynamic Properties of Meropenem

    David P. Nicolau

  • Carbapenems: a potent class of antibiotics.

    David P Nicolau

  • Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge

    Unknown

  • Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae

    Catharine C. Bulik;David P. Nicolau

  • Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)

    Massimo Sartelli;Dieter G. Weber;Etienne Ruppé;Matteo Bassetti

  • Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients

    Chonghua Li;Joseph L. Kuti;Charles H. Nightingale;David P. Nicolau

  • Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.

    Unknown

  • Adherence to Highly Active Antiretroviral Therapy Predicts Virologic Outcome at an Inner-City Human Immunodeficiency Virus Clinic

    JoCarol McNabb;Jack W. Ross;Kenneth Abriola;Christina Turley

  • Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia.

    David P Nicolau;JoCarol McNabb;Melinda K Lacy;Richard Quintiliani

  • Relationship between Fluoroquinolone Use and Changes in Susceptibility to Fluoroquinolones of Selected Pathogens in 10 United States Teaching Hospitals, 1991–2000

    Marcus J. Zervos;Marcus J. Zervos;Ellie Hershberger;Ellie Hershberger;David P. Nicolau;David J. Ritchie;David J. Ritchie

  • Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.

    Abrar K Thabit;Jared L Crandon;David P Nicolau

  • Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria

    Matteo Bassetti;Jan J. De Waele;Philippe Eggimann;Josè Garnacho-Montero

  • Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study.

    Su Young Lee;Srividya Kotapati;Joseph L Kuti;Charles H Nightingale

  • Randomized, Open-Label, Comparative Study of Piperacillin-Tazobactam Administered by Continuous Infusion versus Intermittent Infusion for Treatment of Hospitalized Patients with Complicated Intra-Abdominal Infection

    William K. Lau;David Mercer;Kamal M. Itani;David P. Nicolau

  • The Current State of Multidrug-Resistant Gram-Negative Bacilli in North America

    Anthony M Nicasio;Joseph L Kuti;David P Nicolau

  • Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital.

    Edward M. Grant;Joseph L. Kuti;David P. Nicolau;Charles Nightingale

Frequent Co-Authors

Joseph L. Kuti
Joseph L. Kuti Hartford Hospital
Charles H. Nightingale
Charles H. Nightingale University of Connecticut
Richard Quintiliani
Richard Quintiliani Hartford Hospital
Jason A. Roberts
Jason A. Roberts University of Queensland
Matteo Bassetti
Matteo Bassetti University of Genoa
Cesar A. Arias
Cesar A. Arias The University of Texas Health Science Center at Houston
Antoni Torres
Antoni Torres University of Barcelona
Stephen G. Jenkins
Stephen G. Jenkins Cornell University
Michael J. Satlin
Michael J. Satlin Cornell University
Helen Giamarellou
Helen Giamarellou National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge beyond microbiology, several related online degrees offer promising career opportunities. Many students explore online public health masters programs easy to get into, which provide valuable skills in disease prevention and health promotion. These programs often complement a microbiology background and open doors to leadership roles in healthcare and research.

Careers like becoming a child specialist salary professional demonstrate how specialized training can lead to rewarding paths focused on improving individual patient outcomes. This highlights the importance of targeted education combined with practical experience.

Additionally, those with unique challenges may find hope through degrees tailored for a diverse range of students, including degrees felons can get. These programs aim to provide accessible education and career advancement opportunities, reducing barriers for success.

Another emerging field is becoming a functional nurse practitioner, where professionals blend holistic approaches with traditional healthcare. This career path benefits from a strong science foundation like microbiology, combined with patient-centered care training.

Best Scientists Citing David P. Nicolau

Trending Scientists

Recently Published Articles